Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_assertion type Assertion NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_head.
- NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_assertion description "[Materials and methods Immunoreactivity for bcl-2 was examined in 10 samples of benign prostatic hyperplasia (BPH), 13 of primary prostatic adenocarcinoma, 15 of high-grade PIN and 18 of low-grade PIN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_provenance.
- NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_assertion evidence source_evidence_literature NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_provenance.
- NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_assertion SIO_000772 10619965 NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_provenance.
- NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_assertion wasDerivedFrom befree-20150227 NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_provenance.
- NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_assertion wasGeneratedBy ECO_0000203 NP263985.RAHK8CyL0lZcwAsbQkgOdYoZ5PWhEBH0t4yTtzwfQysg0130_provenance.